| Primary |
| Neuralgia |
40.0% |
| Pain |
40.0% |
| Exposure During Pregnancy |
20.0% |
|
| Somnolence |
80.0% |
| Poor Sucking Reflex |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
45.6% |
| Bipolar I Disorder |
14.2% |
| Drug Use For Unknown Indication |
9.3% |
| Bipolar Disorder |
3.9% |
| Psychotic Disorder |
3.8% |
| Foetal Exposure During Pregnancy |
2.8% |
| Depression |
2.3% |
| Prophylaxis |
2.2% |
| Panic Disorder |
2.0% |
| Schizophrenia |
2.0% |
| Mental Disorder |
1.9% |
| Hiv Infection |
1.5% |
| Self Injurious Behaviour |
1.4% |
| Abnormal Behaviour |
1.3% |
| Epilepsy |
1.3% |
| Anxiety |
1.0% |
| Mania |
1.0% |
| Bone Marrow Conditioning Regimen |
0.9% |
| Ill-defined Disorder |
0.9% |
| Affective Disorder |
0.8% |
|
| Toxic Epidermal Necrolysis |
12.8% |
| Vomiting |
8.1% |
| Renal Failure |
7.0% |
| Somnolence |
7.0% |
| Sopor |
7.0% |
| Respiratory Distress |
5.8% |
| Rhabdomyolysis |
5.8% |
| Intentional Self-injury |
4.7% |
| Intra-uterine Death |
4.7% |
| Self-injurious Ideation |
4.7% |
| Transaminases Increased |
4.7% |
| Hepatitis |
3.5% |
| Hyponatraemia |
3.5% |
| Pyrexia |
3.5% |
| Self Injurious Behaviour |
3.5% |
| Thrombocytopenia |
3.5% |
| Vaginitis Gardnerella |
3.5% |
| Hydrocephalus |
2.3% |
| Malaise |
2.3% |
| Neuroleptic Malignant Syndrome |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.2% |
| Product Used For Unknown Indication |
23.8% |
| Gastric Cancer |
11.1% |
| Depression |
5.0% |
| Nausea |
3.9% |
| Prophylaxis |
3.5% |
| Hiv Infection |
3.2% |
| Schizophrenia |
2.6% |
| Acute Myeloid Leukaemia |
2.5% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Anxiety |
2.3% |
| Bipolar I Disorder |
2.3% |
| Psychotic Disorder |
1.9% |
| Vomiting |
1.9% |
| Hypertension |
1.8% |
| Ankylosing Spondylitis |
1.7% |
| Schizoaffective Disorder |
1.7% |
| Insomnia |
1.6% |
| Aggression |
1.5% |
| Pain |
1.5% |
|
| Hypokalaemia |
16.3% |
| Vomiting |
8.1% |
| Weight Increased |
8.1% |
| Febrile Neutropenia |
7.4% |
| Toxic Skin Eruption |
7.4% |
| Stevens-johnson Syndrome |
5.9% |
| Schizophrenia |
4.4% |
| Serotonin Syndrome |
4.4% |
| Death |
3.7% |
| Drug Interaction |
3.7% |
| Hyponatraemia |
3.7% |
| Weight Decreased |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Renal Failure |
3.0% |
| Retrognathia |
3.0% |
| Somnolence Neonatal |
3.0% |
| Sudden Death |
3.0% |
| Thrombocytopenia |
3.0% |
| Cystitis Haemorrhagic |
2.2% |
| Hepatitis |
2.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
44.4% |
| Anxiety |
11.1% |
| Bipolar Disorder |
11.1% |
| Fungal Infection |
7.4% |
| Hiv Infection |
7.4% |
| Insomnia |
7.4% |
| Nausea |
7.4% |
| Depression |
3.7% |
|
| Orthostatic Hypotension |
33.3% |
| Hallucination, Visual |
22.2% |
| Labelled Drug-drug Interaction Medication Error |
11.1% |
| Petit Mal Epilepsy |
11.1% |
| Urinary Retention |
11.1% |
| Weight Increased |
11.1% |
|
